Skip to main content

Mind Medicine

corporate_fare Company Profile

Mind Medicine

MNMD·NASDAQ·Healthcare·CIK 0000945801

Definium Therapeutics, Inc. is a New York-based biotechnology company that develops clinical and therapeutic applications for psychedelic and psychoplastogenic drugs.

Mind Medicine (NASDAQ:MNMD) is a publicly traded company in the Healthcare sector. Wiseek has independently scored 1 item for MNMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-01-12, rated 8/10. Recent SEC coverage for MNMD spans 8-K.

Recent high-impact activity:

  • Mind Medicine Rebrands to Definium Therapeutics, Reports $412M Cash for Runway into 2028
$14.9
52-week range · as of 2026-01-12 $4.7 – $15.29
Market cap
$1.48B
Volume
2.1M (1.0× avg)
3-mo avg 2.1M
Last traded · 2026-01-15

show_chartPrice Chart

Loading chart...

feed MNMD - Latest Insights

MNMD
Jan 12, 2026, 8:24 AM EST
Filing Type: 8-K
Importance Score:
8
Mind Medicine Rebrands to Definium Therapeutics, Reports $412M Cash for Runway into 2028
Price at Filing: $14.10
Real-time Price: $14.90 info
Change: +$0.800 (+6%) info
Market Cap: $1.48B info
Sentiment: Positive
View Wiseek Article
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets